X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (135) 135
female (131) 131
oncology (94) 94
adult (85) 85
middle aged (68) 68
index medicus (62) 62
aged (56) 56
ovarian cancer (50) 50
chemotherapy (46) 46
cancer (45) 45
obstetrics & gynecology (44) 44
ovarian neoplasms - pathology (43) 43
carcinoma (39) 39
retrospective studies (39) 39
prognosis (35) 35
neoplasm staging (34) 34
surgery (34) 34
treatment outcome (34) 34
ovarian neoplasms - surgery (31) 31
adolescent (26) 26
survival (25) 25
antineoplastic combined chemotherapy protocols - therapeutic use (23) 23
combined modality therapy (22) 22
ovarian neoplasms - drug therapy (22) 22
tumors (21) 21
cervical cancer (20) 20
management (20) 20
recurrence (19) 19
young adult (19) 19
antineoplastic agents - therapeutic use (18) 18
fertility (18) 18
uterine cervical neoplasms - pathology (18) 18
aged, 80 and over (17) 17
care and treatment (17) 17
disease-free survival (17) 17
male (17) 17
follow-up studies (16) 16
pregnancy (16) 16
obstetrics and gynecology (15) 15
gynecologic-oncology-group (14) 14
hematology, oncology and palliative medicine (14) 14
survival rate (14) 14
ovarian neoplasms - therapy (13) 13
radiotherapy (13) 13
reproductive biology (13) 13
conservative surgery (12) 12
hysterectomy (12) 12
lymph node excision (12) 12
lymphadenectomy (12) 12
sarcoma (12) 12
medicine & public health (11) 11
neoplasm recurrence, local - pathology (11) 11
peritoneal implants (11) 11
therapy (11) 11
brachytherapy (10) 10
lymphatic metastasis (10) 10
metastasis (10) 10
bevacizumab (9) 9
chemotherapy, adjuvant (9) 9
endometrial neoplasms - pathology (9) 9
ovary (9) 9
prognostic-factors (9) 9
risk factors (9) 9
survival analysis (9) 9
targeted therapy (9) 9
uterine cervical neoplasms - surgery (9) 9
uterine cervical neoplasms - therapy (9) 9
uterine cervix (9) 9
uterine neoplasms - pathology (9) 9
antineoplastic agents - adverse effects (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (8) 8
conservative treatment (8) 8
cystadenocarcinoma, serous - pathology (8) 8
cystadenocarcinoma, serous - surgery (8) 8
ovarian neoplasms - genetics (8) 8
paclitaxel - administration & dosage (8) 8
prognostic factors (8) 8
surgical oncology (8) 8
uterus (8) 8
women (8) 8
child (7) 7
cisplatin (7) 7
clinical trials (7) 7
drug therapy (7) 7
endometrial cancer (7) 7
imatinib mesylate (7) 7
mutation (7) 7
neoplasm recurrence, local (7) 7
neoplasms, glandular and epithelial - pathology (7) 7
ovarian neoplasms - mortality (7) 7
radiation-therapy (7) 7
uterine cervical neoplasms - drug therapy (7) 7
uterine cervical neoplasms - radiotherapy (7) 7
analysis (6) 6
behavior (6) 6
borderline ovarian tumor (6) 6
cancer therapies (6) 6
carcinoma, ovarian epithelial (6) 6
chemoradiotherapy (6) 6
cisplatin - therapeutic use (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Bulletin du Cancer, ISSN 0007-4551, 12/2017, Volume 104, Issue 12, pp. 1046 - 1053
Endometrial cancer has generally a good prognosis when diagnosed at an early stage, but remains incurable at an advanced stage (recurrent or metastatic) with... 
Chemotherapy | Endometrial cancer | Targeted therapy | Hormonal therapy
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2019, Volume 380, Issue 23, pp. 2274 - 2275
To the Editor: Harter et al. (Feb. 28 issue) 1 report the results of the Lymphadenectomy in Ovarian Neoplasms (LION) trial, which answered questions that had... 
Lymph Node Excision | Female | Humans | Ovarian Neoplasms - surgery | Peritoneal diseases | Medical imaging | Nuclear magnetic resonance--NMR | Computed tomography | Ultrasonography | Peritoneum | Tumors
Journal Article
by Pujade-Lauraine, Eric and Ledermann, Jonathan and Ledermann, Jonathan A and Selle, Frédéric and Gebski, Val and Penson, Richard and Penson, Richard T and Oza, Amit M and Oza, Amit and Korach, Jacob and Huzarski, Tomasz and Poveda, Andrés and Pignata, Sandro and Friedlander, Michael and Colombo, Nicoletta and Harter, Philipp and Fujiwara, Keiichi and Ray-Coquard, Isabelle and Banerjee, Susana and Liu, Joyce and Lowe, Elizabeth S and Bloomfield, Ralph and Pautier, Patricia and Byrski, Tomasz and Scambia, Giovanni and Nicoletto, Maria and Nussey, Fiona and Clamp, Andrew and Poveda Velasco, Andrés and Rodrigues, Manuel and Lotz, Jean-Pierre and Provencher, Diane and Prat Aparicio, Aleix and Vidal Boixader, Laura and Scott, Clare and Tamura, Kenji and Yunokawa, Mayu and Lisyanskaya, Alla and Medioni, Jacques and Pécuchet, Nicolas and Dubot, Coraline and de la Motte Rouge, Thibault and Kaminsky, Marie-Christine and Weber, Béatrice and Lortholary, Alain and Parkinson, Christine and Williams, Sarah and Cosin, Jonathan and Hoffman, James and Plante, Marie and Covens, Allan and Sonke, Gabe and Joly, Florence and Floquet, Anne and Hirte, Holger and Amit, Amnon and Park-Simon, Tjoung-Won and Matsumoto, Koji and Tjulandin, Sergei and Kim, Jae Hoon and Kim, Byoung-Gie and Kim, Jae Weon and Gladieff, Laurence and Sabbatini, Roberto and O'Malley, David and Timmins, Patrick and Kredentser, Daniel and Laínez Milagro, Nuria and Barretina Ginesta, Maria Pilar and Tibau Martorell, Ariadna and Gómez de Liaño Lista, Alfonso and Ojeda González, Belén and Mileshkin, Linda and Mandai, Masaki and Boere, Ingrid and Ottevanger, Petronella and Nam, Joo-Hyun and Filho, Elias and Hamizi, Salima and Cognetti, Francesco and Warshal, David and Dickson-Michelson, Elizabeth and Kamelle, Scott and McKenzie, Nathalie and Rodriguez, Gustavo and Armstrong, Deborah and Chalas, Eva and Celano, Paul and Behbakht, Kian and Davidson, Susan and Welch, Stephen and Helpman, Limor and Fishman, Ami and Bruchim, Ilan and Sikorska, Magdalena and Słowińska, Anna and Rogowski, Wojciech and Bidziński, Mariusz and Śpiewankiewicz, Beata and Casado Herraez, Antonio and ... and SOLO2-ENGOT-Ov21 Investigators and SOLO2/ENGOT-Ov21 investigators
The Lancet Oncology, ISSN 1470-2045, 09/2017, Volume 18, Issue 9, pp. 1274 - 1284
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 4, pp. 457 - 464
Journal Article
Fertility and Sterility, ISSN 0015-0282, 2016, Volume 106, Issue 5, pp. 1195 - 1211.e5
Journal Article
Future Oncology, ISSN 1479-6694, 07/2018, Volume 14, Issue 17, pp. 1669 - 1678
Mirvetuximab soravtansine, an antibody-drug conjugate that binds with high affinity to folate receptor-alpha to provide tumor-directed delivery of the potent... 
Phase III trial | targeted therapy | antibody-drug conjugate | mirvetuximab soravtansine | ovarian cancer | folate receptor-α | PEGYLATED LIPOSOMAL DOXORUBICIN | SOLID TUMORS | folate receptor-alpha | FALLOPIAN-TUBE | TRIAL | IMGN853 | ONCOLOGY | SINGLE-AGENT PACLITAXEL | PLATINUM/PACLITAXEL-REFRACTORY OVARIAN | EXPRESSION
Journal Article
Expert Review of Anticancer Therapy, ISSN 1473-7140, 06/2019, Volume 19, Issue 6, pp. 437 - 446
Introduction: The landscape of poly (ADP-ribose) polymerase (PARP) inhibition in ovarian cancer is rapidly evolving and becoming increasingly complex. Ovarian... 
Rucaparib | ovarian cancer | PARP inhibitor | synthetic lethality | SAFETY | MECHANISMS | OLAPARIB MONOTHERAPY | MAINTENANCE THERAPY | ONCOLOGY | DOUBLE-BLIND | RESISTANCE | HOMOLOGOUS RECOMBINATION | CARCINOMA | EXPRESSION | GERMLINE BRCA1/2 MUTATION
Journal Article
Journal Article
Journal Article
Sarcoma, ISSN 1357-714X, 2015, Volume 2015, pp. 704124 - 14
The treatment of advanced uterine leiomyosarcomas (U-LMS) represents a considerable challenge. Radiological diagnosis prior to hysterectomy is difficult, with... 
Care and treatment | Evidence-based medicine | Methods | Leiomyosarcoma | Review
Journal Article
European Journal of Cancer, ISSN 0959-8049, 07/2019, Volume 116, pp. 35 - 44
Journal Article
Journal Article